96 related articles for article (PubMed ID: 24761989)
21. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis for benzimidazole resistance from a novel β-tubulin binding site model.
Aguayo-Ortiz R; Méndez-Lucio O; Romo-Mancillas A; Castillo R; Yépez-Mulia L; Medina-Franco JL; Hernández-Campos A
J Mol Graph Model; 2013 Sep; 45():26-37. PubMed ID: 23995453
[TBL] [Abstract][Full Text] [Related]
23. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
[TBL] [Abstract][Full Text] [Related]
24. Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.
Ravi M; Zask A; Rush TS
Biochemistry; 2005 Dec; 44(48):15871-9. PubMed ID: 16313189
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics modeling of tubulin C-terminal tail interactions with the microtubule surface.
Freedman H; Luchko T; Luduena RF; Tuszynski JA
Proteins; 2011 Oct; 79(10):2968-82. PubMed ID: 21905119
[TBL] [Abstract][Full Text] [Related]
26. Helicity of alpha(404-451) and beta(394-445) tubulin C-terminal recombinant peptides.
Jimenez MA; Evangelio JA; Aranda C; Lopez-Brauet A; Andreu D; Rico M; Lagos R; Andreu JM; Monasterio O
Protein Sci; 1999 Apr; 8(4):788-99. PubMed ID: 10211825
[TBL] [Abstract][Full Text] [Related]
27. Diastereomers of dibromo-7-epi-10-deacetylcephalomannine: crowded and cytotoxic taxanes exhibit halogen bonds.
Jiang Y; Alcaraz AA; Chen JM; Kobayashi H; Lu YJ; Snyder JP
J Med Chem; 2006 Mar; 49(6):1891-9. PubMed ID: 16539375
[TBL] [Abstract][Full Text] [Related]
28. High-content analysis of cancer-cell-specific apoptosis and inhibition of in vivo angiogenesis by synthetic (-)-pironetin and analogs.
Vogt A; McPherson PA; Shen X; Balachandran R; Zhu G; Raccor BS; Nelson SG; Tsang M; Day BW
Chem Biol Drug Des; 2009 Oct; 74(4):358-68. PubMed ID: 19691472
[TBL] [Abstract][Full Text] [Related]
29. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
[TBL] [Abstract][Full Text] [Related]
30. A molecular docking study of anticancer drug paclitaxel and its analogues.
Sinha R; Vidyarthi AS; Shankaracharya
Indian J Biochem Biophys; 2011 Apr; 48(2):101-5. PubMed ID: 21682141
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
[TBL] [Abstract][Full Text] [Related]
32. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
Yang Y; Alcaraz AA; Snyder JP
J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
[TBL] [Abstract][Full Text] [Related]
33. Structure Elucidation, Conformation, and Configuration of Cytotoxic 6-Heptyl-5,6-dihydro-2 H-pyran-2-ones from Hyptis Species and Their Molecular Docking to α-Tubulin.
Martínez-Fructuoso L; Pereda-Miranda R; Rosas-Ramírez D; Fragoso-Serrano M; Cerda-García-Rojas CM; da Silva AS; Leitão GG; Leitão SG
J Nat Prod; 2019 Mar; 82(3):520-531. PubMed ID: 30601004
[TBL] [Abstract][Full Text] [Related]
34. Interpreting a medium-resolution model of tubulin: comparison of zinc-sheet and microtubule structure.
Wolf SG; Nogales E; Kikkawa M; Gratzinger D; Hirokawa N; Downing KH
J Mol Biol; 1996 Oct; 262(4):485-501. PubMed ID: 8893858
[TBL] [Abstract][Full Text] [Related]
35. Refined structure of alpha beta-tubulin at 3.5 A resolution.
Löwe J; Li H; Downing KH; Nogales E
J Mol Biol; 2001 Nov; 313(5):1045-57. PubMed ID: 11700061
[TBL] [Abstract][Full Text] [Related]
36. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
[TBL] [Abstract][Full Text] [Related]
37. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.
Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370
[No Abstract] [Full Text] [Related]
38. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
Snyder JP; Nettles JH; Cornett B; Downing KH; Nogales E
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5312-6. PubMed ID: 11309480
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the binding mode of laulimalide to microtubules: Establishing a laulimalide-tubulin pharmacophore.
Churchill CD; Klobukowski M; Tuszynski JA
J Biomol Struct Dyn; 2016 Jul; 34(7):1455-69. PubMed ID: 26230757
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic insights into ring-opening and decarboxylation of 2-pyrones in liquid water and tetrahydrofuran.
Chia M; Haider MA; Pollock G; Kraus GA; Neurock M; Dumesic JA
J Am Chem Soc; 2013 Apr; 135(15):5699-708. PubMed ID: 23517240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
